Risk factors for thrombus formation on the amplatzer cardiac plug after left atrial appendage occlusion

JACC: Cardiovascular Interventions

Volumn 6, Issue 6, 2013, Pages 606-613

  Plicht, Bjoern ^a   Konorza, Thomas F M ^a   Kahlert, Philipp ^a   Al Rashid, Fadi ^a   Kaelsch, Hagen ^a   Jánosi, Rolf Alexander ^a   Buck, Thomas ^a   Bachmann, Hagen S ^a   Siffert, Winfried ^a   Heusch, Gerd ^a   Erbel, Raimund ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

atrial fibrillation; device thrombus; hemostaseology; left atrial appendage occlusion; transesophageal echocardiography

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIVITAMIN K;

AGED; AMPLATZER VASCULAR PLUG; ARTICLE; CARDIOEMBOLIC STROKE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHADS2 SCORE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT ATRIAL APPENDAGE VELOCITY; HEART LEFT ATRIAL VOLUME; HOSPITAL DISCHARGE; HUMAN; INTRACARDIAC THROMBOSIS; LEFT ATRIAL APPENDAGE OCCLUSION; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPONTANEOUS ECHO CONTRAST; THROMBOCYTE COUNT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSMITRAL GRADIENT;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SEPTAL OCCLUDER DEVICE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879335498     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.02.014     Document Type: Article

References (30)

1. A.J. Camm, P. Kirchhof, G.Y. Lip European Heart Rhythm Association, the European Association for Cardio-Thoracic Surgery Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
2. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
3. T.J. Bungard, M.L. Ackman, G. Ho, and R.T. Tsuyuki Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital Pharmacotherapy 20 2000 1060 1065
4. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759
5. D. Fatkin, T. Loupas, N. Jacobs, and M.P. Feneley Quantification of blood echogenicity: evaluation of a semiquantitative method of grading spontaneous echo contrast Ultrasound Med Biol 21 1995 1191 1198
6. T. Buck, B. Plicht, and R. Erbel [Current recommendations on echocardiographic evaluation of the severity of mitral regurgitation: standardization and practical application using a scoring system] Herz 31 2006 30 37
7. J.S. Miles, J.P. Miletich, S.Z. Goldhaber, C.H. Hennekens, and P.M. Ridker G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism J Am Coll Cardiol 37 2001 215 218
8. P.M. Ridker, C.H. Hennekens, K. Lindpaintner, M.J. Stampfer, P.R. Eisenberg, and J.P. Miletich Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men N Engl J Med 332 1995 912 917
9. A. Sazci, E. Ergul, N. Tuncer, G. Akpinar, and I. Kara Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C Brain Res Bull 71 2006 45 50
10. D. Voora, and G.S. Ginsburg Clinical application of cardiovascular pharmacogenetics J Am Coll Cardiol 60 2012 9 20
11. D. Sibbing, W. Koch, and D. Gebhard Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement Circulation 121 2010 512 518
12. H.J. Bouman, E. Schomig, and J.W. van Werkum Paraoxonase-1 is a major determinant of clopidogrel efficacy Nat Med 17 2011 110 116
13. V.Y. Reddy, S.K. Doshi, H. Sievert PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3 year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial Circulation 127 2013 720 729
14. B. Meier, I. Palacios, and S. Windecker Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation Catheter Cardiovasc Interv 60 2003 417 422
15. J.W. Park, A. Bethencourt, and H. Sievert Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
16. I. Cruz-Gonzalez, J. Martín Moreiras, and E. García Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device Catheter Cardiovasc Interv 78 2011 970 973
17. L. Cardona, G. Ana, and B. Luísa Thrombus formation on a left atrial appendage closure device Circulation 124 2011 1595 1596
18. J.R. López-Minguez, J. Eldoayen-Gragera, and R. González-Fernández Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer Cardiac Plug Rev Esp Cardiol 66 2013 90 97
19. V.Y. Reddy, D. Holmes, S.K. Doshi, P. Neuzil, and S. Kar Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424
20. A. Braut, P. Neuzil, and G. Schuler LAA closure with the Watchman device in patients with contraindications to warfarin: preliminary results from the ASA Plavix Registry (ASAP) (abstr) Eur Heart J 32 2011 6 7
21. J.M. Sherman, D.J. Hagler, and F. Cetta Thrombosis after septal closure device placement: a review of the current literature Catheter Cardiovasc Interv 63 2004 486 489
22. U. Krumsdorf, S. Ostermayer, and K. Billinger Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients J Am Coll Cardiol 43 2004 302 309
23. J.L. Bass Transcatheter occlusion of the left atrial appendage - experimental testing of a new Amplatzer device Catheter Cardiovasc Interv 76 2010 181 185
24. J. Rodés-Cabau, J. Champagne, and M. Bernier Transcatheter closure of the left atrial appendage: initial experience with the Amplatzer cardiac plug device Catheter Cardiovasc Interv 76 2010 186 192
25. Y.Y. Lam, G.W. Yip, and C.M. Yu Left atrial appendage closure with Amplatzer cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience Catheter Cardiovasc Interv 79 2012 794 800
26. 2 score is predictive of left atrial thrombus on precardioversion transesophageal echocardiography in atrial fibrillation Am J Cardiovasc Dis 1 2011 159 165
27. S. Ayirala, S. Kumar, D.M. O'Sullivan, and D.I. Silverman Echocardiographic predictors of left atrial appendage thrombus formation J Am Soc Echocardiogr 24 2011 499 505
28. M. Yuce, M. Cakici, and V. Davutoglu Relationship between mean platelet volume and atrial thrombus in patients with atrial fibrillation Blood Coagul Fibrinolysis 21 2010 722 725
29. G.K. Paul, B. Sen, and M.A. Bari Correlation of platelet count and acute ST-elevation in myocardial infarction Mymensingh Med J 19 2010 469 473
30. S.J. Turner, T.R. Ketch, S.K. Gandhi, and D.C. Sane Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes Am Heart J 155 2008 806 816